Viatris Inc (VTRS)

Nov 29, 2024

Viatris Says Goodbye To Another Generics Asset - Citeline

Nov 29, 2024

Nov 27, 2024

2 Generic Drug Stocks Ready to Surge in 2025 - MarketBeat

Nov 27, 2024

Nov 26, 2024

Hypopituitarism Treatment Market to Witness Huge Growth - openPR

Nov 26, 2024

Nov 26, 2024

Hypovolemic Shock Market Growth Analysis: Industry Expansion - openPR

Nov 26, 2024

Nov 25, 2024

UK CMA fines Viatris for breaching order during Theramex deal probe - World Pharmaceutical Frontiers

Nov 25, 2024

Nov 24, 2024

Viatris fined in Morocco over merger notification, sources say - MSN

Nov 24, 2024

Nov 24, 2024

Vitaris fined in Morocco over merger notification, sources say - MSN

Nov 24, 2024

Nov 23, 2024

Morocco fines Viatris 7.58 million dirhams over Mylan-Pfizer merger - MSN

Nov 23, 2024

Nov 22, 2024

Viatris Reports Third Quarter Financial Results for 2024 - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

UK watchdog fines Viatris $1.9 mln over rule breach in Theramex probe - Reuters.com

Nov 22, 2024

Nov 22, 2024

Viatris Fined £1.5M For Failing To Comply With CMA Order - Law360

Nov 22, 2024

Nov 22, 2024

Viatris fined £1.5M for failure to comply with CMA order - MSN

Nov 22, 2024

Nov 22, 2024

Viatris fined £1.5M for failure to comply with CMA order (NASDAQ:VTRS) - Seeking Alpha

Nov 22, 2024

Nov 22, 2024

UK watchdog fines Viatris $1.9 million over rule breach in Theramex probe - Marketscreener.com

Nov 22, 2024

Nov 22, 2024

Viatris Fined £1.5M for CMA Order Breach - Mirage News

Nov 22, 2024

Nov 22, 2024

Viatris fined £1.5m for failure to comply with CMA order - GOV.UK

Nov 22, 2024

Nov 22, 2024

Ampicillin Market to Continue Impressive Measured Growth - openPR

Nov 22, 2024

Nov 21, 2024

Samsung Ends Antitrust Dispute with Broadcom After Five Months - PYMNTS.com

Nov 21, 2024

Nov 21, 2024

Viatris fined in Morocco over merger notification, sources say By Reuters - Investing.com

Nov 21, 2024

Nov 21, 2024

Viatris Fined in Morocco Over Merger Notification, Sources Say - U.S News & World Report Money

Nov 21, 2024

Nov 21, 2024

Psoriasis Biosimilars Market Key Players AnalysisMerck KGaA, - openPR

Nov 21, 2024

Nov 21, 2024

United States Active Pharmaceutical Ingredients (API) Market May See a Big Move | Merck, Novartis, Viatris, Lupin - openPR

Nov 21, 2024

Nov 20, 2024

Ex-Dividend Reminder: NextEra Energy, CRH and Viatris - Nasdaq

Nov 20, 2024

Nov 20, 2024

Viatris Inc.: Expansion of Innovative Portfolio As A Vital Factor Driving Growth!Major Drivers - Smartkarma

Nov 20, 2024

Nov 19, 2024

Viatris Inc. Rings the Closing Bell - Nasdaq

Nov 19, 2024

Nov 19, 2024

Catecholamines Drugs Market Specialized New Report, See Growth - openPR

Nov 19, 2024

Nov 19, 2024

Cerebral Palsy Treatment Market Growth Overview: - openPR

Nov 19, 2024

Nov 19, 2024

Transdermal Skin Patches Market Overall Study Report 2024-2031 - openPR

Nov 19, 2024

Nov 18, 2024

Safecor Health Acquires Viatris’ U.S. Unit-Dose Packaging Business - citybiz

Nov 18, 2024

Nov 18, 2024

Safecor Health Announces Acquisition of Viatris' U.S. Unit-Dose Packaging Business - PR Newswire

Nov 18, 2024

Nov 18, 2024

VSCP-backed Safecor Health picks up Viatris Inc’s US unit-dose packaging business - PE Hub

Nov 18, 2024

Nov 15, 2024

Influenza Vaccines Industry May See a Big Move | BIKEN, Viatris, Sinovac Biotech - openPR

Nov 15, 2024

Nov 13, 2024

Chris Davis's Strategic Acquisition of Viatris Inc Shares - GuruFocus.com

Nov 13, 2024

Nov 13, 2024

Viatris's SWOT analysis: generic drug maker's stock faces growth hurdles - Investing.com

Nov 13, 2024

Nov 12, 2024

Viatris Inc's chief accounting officer sells $346,686 in stock - Investing.com India

Nov 12, 2024

Nov 12, 2024

Viatris Inc's chief accounting officer sells $346,686 in stock By Investing.com - Investing.com Australia

Nov 12, 2024